PATENT CLAIM ANALYSIS

Application Number: 15751765
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "335000"]

Abstract:
The present invention provides compounds of Formula (I) for the treatment of neurodegenerative or cognitive diseases. The method further provides for piperidine-2-one and piperidine-2-thione intermediates to compounds of formula (I).

Claim (Index 19):
A pharmaceutical composition comprising a compound or pharmaceutically acceptable salt thereof according to  claim 17  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.38462
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15233463', '15524479', '15524565', '15524546', '15231182']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7501878572278162
- 35 USC 102 Novelty (BERT): 0.55465472798948
- Combined Prediction Score: 0.7306345443039826
- Mean Citation Score: 355.62572
- Max Citation Score: 406.83322
- Similarity Product: 355.2950474891853

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test